Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress

Go back to Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
(NASDAQ: RCKT) Delayed: 3.47 +0.01 (0.29%)
Previous Close $3.46    52 Week High
Open $3.40    52 Week Low
Day High $3.63    P/E N/A 
Day Low $3.39    EPS
Volume 2,077,104